{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:26:54Z","timestamp":1787063214139,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejps.2018.06.021","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T01:54:27Z","timestamp":1529546067000},"page":"85-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes"],"prefix":"10.1016","volume":"122","author":[{"given":"G.","family":"Ermondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Camacho-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.06.021_bb0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejps.2018.06.021_bb0010","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1021\/ja303200d","article-title":"Intestinal permeability of cyclic peptides: common key backbone motifs identified","volume":"134","author":"Beck","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0015","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/anie.200705797","article-title":"Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues","volume":"47","author":"Biron","year":"2008","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ejps.2018.06.021_bb0020","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2018.06.021_bb0025","first-page":"752","volume":"28","author":"Caleman","year":"2012"},{"key":"10.1016\/j.ejps.2018.06.021_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.drudis.2016.11.017","article-title":"Updating molecular properties during early drug discovery","volume":"22","author":"Caron","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2018.06.021_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1461-5347(99)00180-7","article-title":"Combined molecular lipophilicity descriptors and their role in understanding intramolecular effects","volume":"2","author":"Caron","year":"1999","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.ejps.2018.06.021_bb0040","series-title":"Comprehensive Medicinal Chemistry II","first-page":"425","article-title":"Lipophilicity, polarity, and hydrophobicity","volume":"Vol. 5","author":"Caron","year":"2006"},{"key":"10.1016\/j.ejps.2018.06.021_bb0045","first-page":"9701","article-title":"Acidic and basic drugs in medicinal chemistry: a perspective","volume":"57","author":"Charifson","year":"2014"},{"key":"10.1016\/j.ejps.2018.06.021_bb0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nprot.2011.450","article-title":"Synthesis of N-methylated cyclic peptides","volume":"7","author":"Chatterjee","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1012911329730","article-title":"Amide proton temperature coefficients as hydrogen bond indicators in proteins","volume":"21","author":"Cierpicki","year":"2001","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.ejps.2018.06.021_bb0060","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1021\/ac103312e","article-title":"Zwitterionic hydrophilic interaction liquid chromatography (ZIC-HILIC and ZIC-cHILIC) provide high resolution separation and increase sensitivity in proteome analysis","volume":"83","author":"Di Palma","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejps.2018.06.021_bb0065","first-page":"4974","article-title":"Development of a new permeability assay using low-efflux","volume":"100","author":"Di","year":"2011"},{"key":"10.1016\/j.ejps.2018.06.021_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejps.2018.01.001","article-title":"Learning how to use IAM chromatography for predicting permeability","volume":"114","author":"Ermondi","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.06.021_bb0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/ja508766b","article-title":"Cell-permeable cyclic peptides from synthetic libraries inspired by natural products","volume":"137","author":"Hewitt","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0080","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method","volume":"21","author":"Jakalian","year":"2000","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.ejps.2018.06.021_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000880","article-title":"Automated builder and database of protein\/membrane complexes for molecular dynamics simulations","volume":"2","author":"Jo","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2018.06.021_bb0095","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2018.06.021_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2018.06.021_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.06.021_bb0110","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11095-010-0303-7","article-title":"Lipophilicity and its relationship with passive drug permeation","volume":"28","author":"Liu","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.06.021_bb0115","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejps.2018.06.021_bb0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2018.06.021_bb0125","doi-asserted-by":"crossref","first-page":"12059","DOI":"10.1002\/anie.201405364","article-title":"Improving on nature: making a cyclic heptapeptide orally bioavailable","volume":"53","author":"Nielsen","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ejps.2018.06.021_bb0130","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1021\/acs.chemrev.6b00838","article-title":"Orally absorbed cyclic peptides","volume":"117","author":"Nielsen","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2018.06.021_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chroma.2012.12.077","article-title":"Hydrophilic interaction liquid chromatography columns classification by effect of solvation and chemometric methods","volume":"1278","author":"Noga","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejps.2018.06.021_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1012092409216","article-title":"Effect of restricted conformational flexibility on the permeation of model hexapeptides across Caco-2 cell monolayers","volume":"14","author":"Okumu","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.06.021_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbpa.2017.03.011","article-title":"ScienceDirect targeting intracellular protein \u2013 protein interactions with cell-permeable cyclic peptides","volume":"38","author":"Qian","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejps.2018.06.021_bb0150","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1039\/c2md20203d","article-title":"Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance","volume":"3","author":"Rand","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejps.2018.06.021_bb0155","doi-asserted-by":"crossref","first-page":"14073","DOI":"10.1021\/ja063076p","article-title":"Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides","volume":"128","author":"Rezai","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0160","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/ja0563455","article-title":"Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers","volume":"128","author":"Rezai","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2018.06.021_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpb.2015.02.028","article-title":"Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3","volume":"92","author":"Schoenherr","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.06.021_bb0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/jm020265j","article-title":"Immobilized artificial membrane HPLC in drug research","volume":"46","author":"Taillardat-Bertschinger","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.06.021_bb0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bmc.2014.11.034","article-title":"Improving the passive permeability of macrocyclic peptides: balancing permeability with other physicochemical properties","volume":"23","author":"Thansandote","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2018.06.021_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2004.02.018","article-title":"Chances and pitfalls of cell penetrating peptides for cellular drug delivery","volume":"58","author":"Tr\u00e9hin","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.06.021_bb0185","first-page":"1","article-title":"Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery","volume":"441","author":"Tsopelas","year":"2016","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ejps.2018.06.021_bb0190","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general AMBER force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2018.06.021_bb0195","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nchembio.664","article-title":"On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds","volume":"7","author":"White","year":"2011","journal-title":"Nat. Chem. Biol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871830277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871830277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T01:00:33Z","timestamp":1534813233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871830277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"alternative-id":["S092809871830277X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.021","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}